bf/NASDAQ:SUPN_icon.jpeg

COM:SUPERNUS

Supernus Pharmaceuticals

  • Stock

Last Close

35.82

22/11 21:00

Market Cap

2.00B

Beta: -

Volume Today

208.17K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
4.15M
-
10.30M
147.99%
13.01M
26.39%
14.69M
12.91%
16.55M
12.65%
20.98M
26.76%
26.14M
24.60%
37.48M
43.35%
67.14M
79.16%
88.75M
32.18%
84.47M
4.82%
average payables
14.49M
-
10.09M
30.38%
3.09M
69.39%
6.18M
100.24%
7.45M
20.45%
5.02M
32.62%
6.67M
32.84%
44.54M
567.93%
98.31M
120.73%
107.01M
8.85%
48.17M
54.99%
average receivables
2.86M
-
11.16M
289.67%
21.59M
93.42%
33.72M
56.18%
53.56M
58.84%
84.25M
57.32%
95.13M
12.91%
114.10M
19.95%
144.90M
26.99%
157.21M
8.50%
154.83M
1.52%
book value per share
1.05
-
1.69
60.69%
2.50
48.27%
3.88
54.83%
5.27
35.96%
8.71
65.35%
11.36
30.38%
14.16
24.61%
15.36
8.53%
16.51
7.48%
0.02
99.90%
capex per share
-0.07
-
-0.01
80.99%
-0.04
215.77%
-0.03
26.87%
-0.04
23.37%
-0.02
59.39%
-0.05
221.56%
-0.07
25.57%
-0.04
41.25%
-0.01
80.07%
-0.00
99.87%
capex to depreciation
-3.17
-
-0.64
79.83%
-2.28
257.50%
-0.67
70.75%
-0.25
62.66%
-0.12
52.11%
-0.41
243.84%
-0.19
53.73%
-0.06
67.00%
-0.00
92.32%
-0.01
35.01%
capex to operating cash flow
0.04
-
-0.08
289.02%
-0.07
14.59%
-0.02
63.37%
-0.02
26.23%
-0.01
63.03%
-0.02
192.14%
-0.02
30.37%
-0.02
35.45%
-0.00
78.08%
-0.00
40.65%
capex to revenue
-0.20
-
-0.00
97.52%
-0.01
199.82%
-0.01
48.82%
-0.01
9.96%
-0.00
69.25%
-0.01
237.49%
-0.01
4.86%
-0.00
46.78%
-0.00
82.49%
-0.00
46.88%
cash per share
4.13
-
2.66
35.61%
1.90
28.48%
2.30
21.11%
2.76
19.90%
6.85
148.20%
6.62
3.30%
8.03
21.27%
6.40
20.34%
8.60
34.38%
0.00
99.95%
days of inventory on hand
2.36K
-
852.03
63.97%
545.44
35.98%
511.63
6.20%
391.12
23.55%
609.89
55.93%
583.39
4.35%
336.24
42.36%
417.99
24.32%
383.08
8.35%
days payables outstanding
6.05K
-
118.10
98.05%
186.94
58.30%
245.29
31.21%
164.18
33.07%
75.94
53.75%
222.18
192.56%
549.21
147.19%
572.26
4.20%
403.17
29.55%
days sales outstanding
153.48
-
51.65
66.35%
65.48
26.77%
70.50
7.67%
79.21
12.35%
91.87
15.99%
81.16
11.66%
98.81
21.75%
93.76
5.11%
90.53
3.44%
86.61
4.33%
debt to assets
0.14
-
0.20
37.02%
0.04
80.56%
0.24
523.67%
0.26
10.66%
0.34
28.17%
0.33
3.20%
0.26
19.67%
0.25
3.51%
0.26
1.76%
0.03
89.90%
debt to equity
0.47
-
0.38
20.39%
0.06
83.99%
0.38
534.18%
0.42
8.78%
0.73
74.33%
0.64
12.61%
0.53
16.75%
0.52
1.07%
0.49
5.58%
0.04
92.71%
dividend yield
earnings yield
-0.38
-
0.06
114.74%
0.02
61.23%
0.07
232.51%
0.03
61.22%
0.06
126.92%
0.09
41.50%
0.10
5.45%
0.03
64.02%
0.03
8.08%
0.00
100.00%
enterprise value
192.34M
-
303.38M
57.73%
583.20M
92.24%
1.16B
99.45%
1.92B
65.26%
1.86B
3.02%
1.44B
22.90%
1.43B
0.83%
1.77B
23.85%
2.26B
27.96%
1.61T
71,005.25%
enterprise value over ebitda
-3.13
-
12.32
494.18%
31.79
157.95%
20.89
34.29%
18.77
10.14%
11.78
37.26%
8.45
28.29%
6.79
19.63%
14.71
116.64%
15.07
2.46%
-304.86K
2,023,448.65%
ev to operating cash flow
-3.32
-
39.23
1,281.99%
18.16
53.72%
17.41
4.10%
16.77
3.69%
14.45
13.81%
10.04
30.52%
10.30
2.56%
13.89
34.83%
19.34
39.24%
14.46K
74,680.05%
ev to sales
16.00
-
2.49
84.47%
4.04
62.45%
5.41
33.98%
6.36
17.56%
4.56
28.32%
3.66
19.73%
2.74
25.16%
3.05
11.17%
3.39
11.18%
2.64K
77,994.63%
free cash flow per share
-1.89
-
0.17
108.92%
0.63
274.18%
1.32
108.50%
2.22
68.32%
2.46
11.09%
2.68
8.68%
2.56
4.25%
2.36
8.16%
2.17
7.91%
0.00
99.91%
free cash flow yield
-0.25
-
0.02
108.11%
0.05
131.08%
0.05
10.98%
0.06
6.65%
0.07
33.26%
0.11
52.20%
0.10
9.73%
0.08
20.76%
0.06
24.72%
0.00
99.89%
graham net net
1.92
-
1.56
19.03%
0.97
37.65%
0.72
25.92%
0.80
10.68%
-1.51
290.31%
-2.65
75.05%
-3.93
48.30%
-7.14
81.49%
-3.45
51.67%
0.00
100.02%
graham number
8.28
-
4.23
48.93%
4.08
3.52%
12.68
211.00%
11.57
8.78%
20.46
76.86%
23.48
14.77%
27.72
18.06%
18.65
32.73%
20.50
9.93%
0.00
99.99%
income quality
0.63
-
0.39
38.03%
2.29
488.93%
0.73
68.04%
2.00
173.24%
1.16
41.93%
1.27
8.94%
1.09
13.89%
2.38
118.27%
1.92
19.13%
84.41
4,286.59%
intangibles to total assets
0.01
-
0.04
278.78%
0.01
86.91%
0.05
930.04%
0.08
59.30%
0.03
62.20%
0.02
33.26%
0.29
1,273.43%
0.53
81.65%
0.48
9.88%
0.56
16.57%
interest coverage
-7.89
-
4.88
161.89%
14.37
194.41%
10.65
25.91%
63.48
496.12%
7.98
87.44%
6.54
17.96%
7.31
11.76%
3.67
49.77%
9.52
159.19%
2.18
77.08%
interest debt per share
0.74
-
0.76
1.36%
0.18
76.52%
1.59
796.58%
2.23
40.26%
6.69
199.88%
7.65
14.48%
7.94
3.76%
8.48
6.82%
8.29
2.24%
0.00
99.99%
inventory turnover
0.15
-
0.43
177.52%
0.67
56.21%
0.71
6.61%
0.93
30.81%
0.60
35.87%
0.63
4.54%
1.09
73.50%
0.87
19.56%
0.95
9.11%
invested capital
0.47
-
0.38
20.39%
0.06
83.99%
0.38
534.18%
0.42
8.78%
0.73
74.33%
0.64
12.61%
0.53
16.75%
0.52
1.07%
0.49
5.58%
0.04
92.71%
market cap
240.14M
-
350.77M
46.07%
638.20M
81.95%
1.25B
95.73%
2.02B
61.92%
1.73B
14.61%
1.24B
28.02%
1.32B
6.48%
1.55B
16.96%
1.91B
23.63%
1.61T
83,816.92%
net current asset value
19.63M
-
42.74M
117.72%
36.12M
15.48%
33.59M
7.01%
71.47M
112.76%
-31.30M
143.80%
-92.21M
194.59%
-128.83M
39.71%
-271.71M
110.91%
-82.15M
69.76%
136.96M
266.71%
net debt to ebitda
0.78
-
-1.93
347.77%
-3.00
55.74%
-1.54
48.51%
-0.98
36.55%
0.87
188.50%
1.14
31.65%
0.48
57.57%
1.81
273.47%
2.30
27.18%
7.94
245.40%
net income per share
-2.90
-
0.47
116.23%
0.30
37.23%
1.84
524.69%
1.13
38.79%
2.13
89.16%
2.16
1.04%
2.41
11.86%
1.01
58.30%
1.13
12.44%
0.00
100.00%
operating cash flow per share
-1.82
-
0.18
110.06%
0.68
269.70%
1.35
99.63%
2.26
67.24%
2.48
9.85%
2.73
10.07%
2.63
3.68%
2.39
8.98%
2.18
9.07%
0.00
99.91%
payables turnover
0.06
-
3.09
5,027.11%
1.95
36.83%
1.49
23.79%
2.22
49.40%
4.81
116.19%
1.64
65.82%
0.66
59.55%
0.64
4.03%
0.91
41.94%
receivables turnover
2.38
-
7.07
197.16%
5.57
21.12%
5.18
7.12%
4.61
10.99%
3.97
13.79%
4.50
13.20%
3.69
17.86%
3.89
5.38%
4.03
3.57%
4.21
4.53%
research and ddevelopement to revenue
1.43
-
0.16
88.82%
0.20
25.70%
0.20
1.34%
0.16
17.58%
0.22
33.00%
0.18
19.36%
0.15
17.03%
0.16
6.90%
0.11
28.39%
0.15
34.93%
return on tangible assets
-0.84
-
0.15
117.91%
0.07
50.38%
0.31
316.94%
0.15
52.62%
0.12
20.48%
0.10
15.10%
0.12
20.07%
0.07
43.22%
0.07
1.27%
0.00
96.59%
revenue per share
0.38
-
2.89
665.24%
3.04
5.32%
4.35
42.89%
5.95
37.02%
7.86
32.08%
7.49
4.72%
9.89
31.99%
10.92
10.39%
12.43
13.87%
0.01
99.91%
roe
-2.76
-
0.28
110.10%
0.12
57.66%
0.48
303.47%
0.21
54.98%
0.25
14.40%
0.19
22.50%
0.17
10.24%
0.07
61.58%
0.07
4.62%
0.00
97.92%
roic
-1.35
-
0.20
114.53%
0.13
33.22%
0.37
182.14%
0.15
59.61%
0.15
2.23%
0.11
22.42%
0.11
1.24%
0.05
56.33%
0.05
1.12%
-0.00
105.13%
sales general and administrative to revenue
0.13
-
0.18
43.03%
0.16
9.48%
shareholders equity per share
1.05
-
1.69
60.69%
2.50
48.27%
3.88
54.83%
5.27
35.96%
8.71
65.35%
11.36
30.38%
14.16
24.61%
15.36
8.53%
16.51
7.48%
0.02
99.90%
stock based compensation to revenue
0.16
-
0.02
86.02%
0.03
31.64%
0.03
5.91%
0.03
1.23%
0.03
1.03%
0.04
36.89%
0.03
15.81%
0.03
2.93%
0.03
14.77%
0.04
67.29%
tangible asset value
32.31M
-
65.92M
104.05%
117.90M
78.85%
175.26M
48.66%
231.46M
32.06%
421.65M
82.17%
570.59M
35.32%
302.61M
46.97%
-86.36M
128.54%
66.72M
177.26%
204.61M
206.66%
tangible book value per share
1.01
-
1.56
53.77%
2.48
59.17%
3.54
42.69%
4.56
28.72%
8.11
77.85%
10.89
34.23%
4.27
60.77%
-1.63
138.08%
1.24
176.45%
0.00
99.70%
working capital
70.76M
-
81.40M
15.03%
49.88M
38.72%
70.66M
41.66%
105.45M
49.23%
332.13M
214.97%
312.06M
6.04%
385.31M
23.47%
286.21M
25.72%
46.19M
83.86%
202.92M
339.28%

All numbers in (except ratios and percentages)